Takeda Pharmaceutical
TAK
#485
Rank
S$57.10 B
Marketcap
$18.01
Share price
0.38%
Change (1 day)
-4.30%
Change (1 year)

Takeda Pharmaceutical (TAK) - Cash on Hand

Cash on Hand as of September 2024 : S$8.54 Billion

According to Takeda Pharmaceutical's latest financial reports the company has S$8.54 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Takeda Pharmaceutical - Cash on Hand chart (from 2008 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-03-31S$5.52 B-43.09%
2022-03-31S$9.69 B-20.8%
2021-03-31S$12.24 B42.21%
2020-03-31S$8.61 B-2.77%
2019-03-31S$8.85 B91.53%
2018-03-31S$4.62 B-1.65%
2017-03-31S$4.70 B-30.18%
2016-03-31S$6.73 B-17.66%
2015-03-31S$8.17 B-21.48%
2014-03-31S$10.41 B40.9%
2013-03-31S$7.39 B5.86%
2012-03-31S$6.98 B-47.32%
2011-03-31S$13.25 B0.33%
2010-03-31S$13.21 B13.28%
2009-03-31S$11.66 B-49.84%
2008-03-31S$23.25 B0.29%
2007-03-31S$23.18 B-9.59%
2006-03-31S$25.64 B9.41%
2005-03-31S$23.44 B10.73%
2004-03-31S$21.17 B23.96%
2003-03-31S$17.07 B39.15%
2002-03-31S$12.27 B18.35%
2001-03-31S$10.37 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$27.32 B 219.80%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.80 B 14.77%๐Ÿ‡ซ๐Ÿ‡ท France
S$13.39 B 56.80%๐Ÿ‡บ๐Ÿ‡ธ USA
S$18.87 B 120.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
S$1.66 B-80.51%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.01 B-88.13%๐Ÿ‡ฎ๐Ÿ‡ณ India
S$12.13 B 41.98%๐Ÿ‡บ๐Ÿ‡ธ USA
S$5.78 B-32.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
S$19.64 B 129.93%๐Ÿ‡บ๐Ÿ‡ธ USA